Allergy Diagnostics Market Research Reveals Path To $13.02 Billion By 2030

The allergy diagnostics sector is rapidly evolving, driven by technological innovations and increasing demand for precise allergy detection methods. This growth is underscored by advancements in diagnostic techniques, automated testing processes, and expanding research efforts, all of which are setting the stage for significant market developments in the near future. Let's delve into the market size, key players, emerging trends, and segmentation details shaping this industry.

Steady Expansion of the Allergy Diagnostics Market to 2030
The allergy diagnostics market is anticipated to expand swiftly, reaching a valuation of $13.03 billion by 2030. This reflects a strong compound annual growth rate (CAGR) of 13.2%. The upward trajectory is fueled by breakthroughs in component-resolved diagnostics, increased automation in allergy testing processes, and heightened investments in research focused on novel allergens. Additionally, the growth of academic and diagnostic laboratories and a rising demand for personalized allergy treatments contribute significantly to this market's momentum. Key trends expected to influence the market's evolution include a growing preference for accurate diagnostics, wider adoption of in-vitro testing techniques, expansion in food and drug allergen testing, and more frequent use of ELISA, RAST, and CRD kits. There is also a heightened emphasis on rapid and point-of-care allergy detection methods.

The allergy diagnostics market size has grown rapidly in recent years. It will grow from $6.99 billion in 2025 to $7.94 billion in 2026 at a compound annual growth rate (CAGR) of 13.5%. The growth in the historic period can be attributed to increasing prevalence of allergies worldwide, adoption of skin prick and intradermal tests, expansion of hospital-based laboratories, growing awareness about allergy management, limited availability of advanced in-vitro kits.

Download a free sample of the allergy diagnostics market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5655&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Leading Industry Players in the Allergy Diagnostics Field
The allergy diagnostics market is shaped by several prominent companies, including bioMérieux SA, Danaher Corporation, HOB Biotech Group Corp. Ltd., HYCOR Biomedical, Lincoln Diagnostics Inc., Omega Diagnostics Group PLC, Siemens Healthineers AG, Thermo Fisher Scientific Inc., PerkinElmer Inc., R-Biopharm AG, Abbott Laboratories, HollisterStier Allergy, NEOGEN Corporation, AESKU.GROUP GmbH, ACON Laboratories Inc., Erba Group, Stallergenes Greer, HAL Allergy Group, INDOOR Biotechnologies Inc., MacroArray Technologies LLC, Phadia AB, Quest Diagnostics, Randox Laboratories Ltd., Eurofins Viracor Inc., and VRL Laboratories.

A notable development occurred in July 2024 when Switzerland-based Roche acquired LumiraDx, a US healthcare company known for its microfluidic immunofluorescence assays, for an undisclosed sum. This acquisition strengthens Roche's diagnostics portfolio and aims to improve patient access to diagnostic testing, particularly within primary care environments.

View the full allergy diagnostics market report:
https://www.thebusinessresearchcompany.com/report/allergy-diagnostics-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Technological Advances Shaping the Allergy Diagnostics Market
Innovation is a major driver within the allergy diagnostics sector, with companies increasingly integrating artificial intelligence (AI) into their testing platforms to boost accuracy and efficiency. AI-powered allergy component testing platforms represent a breakthrough by utilizing AI algorithms to analyze complex allergy data. For example, in May 2023, Metropolis, an Indian pathology and diagnostic center, launched an AI-driven testing platform capable of identifying 127 respiratory allergens, 10 contact allergens, and 158 food allergens. This tool enhances clinicians' ability to personalize treatments by combining component-resolved diagnostics (CRD) with AI, facilitating smarter clinical decisions.

Emerging Patterns in Allergy Diagnostics Technology
Alongside AI adoption, there is a growing focus on improving the speed and accessibility of allergy testing. Market players are emphasizing point-of-care devices and rapid tests that offer timely results, which is crucial for effective allergy management. The integration of automated systems reduces human error and streamlines laboratory workflows, thereby supporting higher throughput in diagnostic laboratories.

Comprehensive Overview of Allergy Diagnostics Market Segments
The allergy diagnostics market is segmented into several key categories to capture its diverse scope:
1) Test Type: In-Vivo Allergy Tests and In-Vitro Allergy Tests
2) Allergen Type: Inhaled Allergens, Food Allergens, and Drug Allergens
3) Products: Consumables and Instruments
4) End Users: Diagnostics Laboratories, Hospital-Based Laboratories, and Academic and Research Institutes

Further subdivisions include:
- In-Vivo Allergy Tests comprising Skin Prick Tests, Intradermal Tests, Patch Tests, and Oral Food Challenge Tests
- In-Vitro Allergy Tests featuring Enzyme-Linked Immunosorbent Assay (ELISA), Radioallergosorbent Test (RAST), Component-Resolved Diagnostics (CRD), and Basophil Activation Tests (BAT)

This detailed segmentation helps highlight the varied testing methods, allergen categories, product types, and end-user groups that collectively drive the allergy diagnostics market forward.

Our 2026 market reports now feature expanded strategic intelligence through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, key technology and future trend analysis, along with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.